A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed‐Methods Feasibility Study
Basic & Clinical Pharmacology & Toxicology · 2026
DOI: 10.1111/bcpt.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Gert Baas und 6 weiteren Autor:innen. Beteiligte Einrichtung: SIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Deprescriptions, Polypharmacy. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
To address challenges in deprescribing, we investigated the feasibility of an intervention consisting of a clinical medication review (CMR) focused on deprescribing, supported by a training programme for healthcare providers (HCPs) among older patients with hyperpolypharmacy (≥ 10 chronic medications) in primary care. A mixed‐methods feasibility study was conducted in six Dutch community pharmacies using Bowen's framework. The intervention comprised HCP training and a five‐step deprescribing‐focused CMR. Within 6 Bowen domains, 18 outcomes were assessed through (patient) questionnaires, interviews (patients, HCPs), process parameters, and medication dispensing data. Five pharmacists conducted CMRs with 24 patients (median age: 84.5 years). The intervention was well accepted by patients and HCPs. However, barriers emerged regarding implementation and practicality . Consultations lacked complete discussion of patient concerns, and pharmacists reported varying levels of confidence in making deprescribing decisions. Time constraints limited the incorporation of deprescribing into CMRs. On average, 1.3 medications per patient were deprescribed. Within a setting of motivated and CMR‐experienced HCPs, adding a focus on deprescribing to CMRs for older patients with hyperpolypharmacy was feasible and well received. Feasibility was supported by high acceptability and deprescribing potential, though barriers in implementation and practicality indicate the need for further evaluation in broader primary care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- SIR Institute for Pharmacy Practice and Policy, Leiden, the Netherlands.
- Department of Pharmacoepidemiology and Clinical Pharmacology, University of Utrecht, Utrecht, the Netherlands.
- Center for Medicine for Older People, Leiden University Medical Center, Leiden, the Netherlands.
ORCID-Profile: Gert Baas
Förderung
- ZonMw
Zitieren
APA
Baas, G., Heringa, M., Verdoorn, S., Kwint, H. F., Badawy, E., Gussekloo, J., & Bouvy, M. (2026). A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed‐Methods Feasibility Study. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70184
Vancouver
Baas G, Heringa M, Verdoorn S, Kwint HF, Badawy E, Gussekloo J, et al. A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed‐Methods Feasibility Study. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70184
BibTeX
@article{Baas2026,
author = {Baas, Gert and Heringa, Mette and Verdoorn, Sanne and Kwint, Henk-Frans and Badawy, Eman and Gussekloo, Jacobijn and Bouvy, Marcel},
title = {A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed‐Methods Feasibility Study},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
doi = {10.1111/bcpt.70184}
}
EUVIMED